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Background: Reduced lung function is associated with incident insulin resistance and diabetes. The aim of this
study was to assess the relationship between lung function and incident type 2 diabetes in Korean men.
Methods: This study included 9,220 men (mean age: 41.4 years) without type 2 diabetes at baseline who were
followed for five years. Subjects were divided into four groups according to baseline forced vital capacity (FVC) (%
predicted) and forced expiratory volume in one second (FEV1) (% predicted) quartiles. The incidence of type 2
diabetes at follow-up was compared according to FVC and FEV1 quartiles.
Results: The overall incidence of type 2 diabetes was 2.2%. Reduced lung function was significantly associated with
the incidence of type 2 diabetes after adjusting for age, BMI, education, smoking, exercise, alcohol, and HOMA-IR.
Both FVC and FEV1 were negatively associated with type 2 diabetes (P< 0.05). In non-obese subjects with BMI< 25,
the lowest quartile of FVC and FEV1 had a significantly higher odds ratio for type 2 diabetes compared with the
highest quartile after adjusting for age and BMI (2.15 [95% CI 1.02-4.57] and 2.19 [95% CI 1.09-4.42]).
Conclusions: Reduced lung function is independently associated with the incidence of type 2 diabetes in Korean
men.
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Obesity is a serious problem that causes various metabolic
diseases [1,2]. Type 2 diabetes is a representative meta-
bolic diseases that is caused by obesity, and recent survey
presents rapidly increasing prevalence of diabetes in Kor-
eans [3].
The association between obesity and respiratory dys-
function is as old as recorded history [4], and obstructive
sleep apnea could be the link that associates obesity with
reduced lung function [5]. In a very recent study by
Fredheim et al. [6] showed direct associations of predia-
betes and type 2 diabetes with obstructive sleep apnea in
extremely obese subjects, suggesting possible link be-
tween sleep apnea, reduced lung function and glucose* Correspondence: kcmd.sung@samsung.com
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reproduction in any medium, provided the orintolerance. From the above algorithm, reduced lung
function as measured by forced vital capacity (FVC) or
forced expiratory volume in one second (FEV1) could be
suggested as the predictor for type 2 diabetes develop-
ment [7-11]. These studies suggest that lung dysfunction
may be associated with the development of type 2 dia-
betes. However, the causal direction between reduced
lung function and diabetes, as well as the underlying
mechanism to explain this association, remains unclear.
Although a number of Asian studies have also revealed
a significant association between reduced lung function
and insulin resistance, metabolic syndrome and type 2
diabetes [12-15], they were limited by their cross-
sectional nature. Here we investigated whether reduced
lung function was a significant predictor of incident type
2 diabetes in Korean men by a five-year follow-up study.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Subjects
Study subjects were selected from a total of 10,965 men
who visited Kangbuk Samsung Hospital Health Promotion
Center for health examinations in both 2003 and 2008. The
purpose of the medical health checkup program is to pro-
mote the health of the employees through regular health
checkups and to enhance early detection of existing dis-
eases, if any. Most of the examinees are the employees
and family members of various industrial companies from
all around the country. The costs of the medical examina-
tions are largely paid for by their employers, and a consid-
erable proportion of the examinees undergo examinations
annually or biannually. We took advantage of this oppor-
tunity to conduct a follow-up study.
Among the potential study subjects, 1,745 individuals
were excluded; 139 individuals had a history of type
2 diabetes, 237 individuals had fasting plasma glucose
≥ 7.0 mmol/L (126 mg/dl) in 2003 (baseline visit), 31 indi-
viduals did not have available FEV1 or FVC level mea-
surements, and 1,338 individuals had no available data
regarding education, alcohol, smoking or exercise. Finally,
9,220 men (mean age: 41.4 years, range: 24 to 82 years)
who did not have type 2 diabetes in 2003 (baseline visit)
were enrolled in the study and were followed up for five
years. The study subjects were divided into quartiles
according to the baseline percentage of predicted values
(% predicted) for FEV1 or FVC. Based on FEV1 (% pre-
dicted), the resulting four categories were as follows:
≤94.6% in quartile 1, 94.6-105.5% in quartile 2, 105.5-
119.9% in quartile 3, and >119.9% in quartile 4. The sub-
jects were similarly divided into quartiles based on FVC
(% predicted): ≤89.4% in quartile 1, 89.4-98.6% in quartile
2, 98.6-109.1% in quartile 3, and ≥109.1% in quartile 4.
We then compared the incidence of type 2 diabetes
according to different FVC (% predicted) and FEV1 (%
predicted) groups after a follow-up survey.
Medical and medication history, smoking status (current-
, ex-, or non-smoker), alcohol consumption (g/day), regular
exercise (≥ once per week), and education status were
assessed using the same standard questionnaire in 2003
and 2008. Blood pressure (BP) was measured with a stand-
ard sphygmomanometer following at least five minutes
of seated rest. Height and weight were estimated using
automated instruments, with individuals wearing light
clothing and no shoes. Body mass index (BMI) was calcu-
lated as body weight (kilograms) divided by height squared
(meters2).
The study protocol conformed to ethical guidelines of the
1975 Declaration of Helsinki, and accordingly the Kangbuk
Samsung Hospital Human Research Committee approved
it. The Kangbuk Samsung Hospital Institutional Review
Board also approved this study and each participant gave
their written informed consent.Measurements
Morning blood samples were drawn from the antecubital
vein after participants had fasted for at least 12 hours.
Plasma glucose levels were determined using the hexoki-
nase method (Advia 1650 AutoAnalyzer, Bayer Diagnostics,
Leverkusen, Germany). Insulin concentrations were mea-
sured using immunoradiometric assays (RIABEAD II,
Abbott, Tokyo, Japan), with intra- and inter-assay coeffi-
cients of variance of 1.2-1.9% and 1.4-3.3%, respectively. In-
sulin resistance was estimated using the homeostasis model
assessment of insulin resistance index (HOMA-IR), which
is defined as fasting insulin (μIU/ml) x fasting glucose
(mmol/L)/22.5 [16]. Fasting total cholesterol (TC) and tri-
glyceride (TG) levels were measured enzymatically using an
automatic analyzer (Advia 1650 AutoAnalyzer, Bayer Diag-
nostics, Leverkusen, Germany). High density lipoprotein
cholesterol (HDL-C) concentrations were measured using
a selective inhibition technique. Levels of low density lipo-
protein cholesterol (LDL-C) were determined through a
homogeneous enzymatic calorimetric test. Type 2 diabetes
was defined as fasting plasma glucose≥ 7.0 mmol/L
(126 mg/dL) based on 1997 American Diabetes Associ-
ation criteria, current usage of diabetes medication, or
positive response to the question, “Has a medical person
ever told you that you had diabetes?” [17].
Lung function assessment
Spirometry was performed as recommended by the
American Thoracic Society [18] using Vmax22 (Sensor-
Medics, Yorba Linda, CA, USA). Absolute values of
FEV1 and FVC were obtained, and the percentage pre-
dicted values (% predicted) for FEV1 and FVC were cal-
culated from the following equations obtained in a
representative Korean population sample [19]:
PredictedFVC ¼ 4:8434 – 0:00008633 x age2 years½ ð Þ
þ 0:05292 x height cm½ ð Þ
þ 0:01095 x weight kg½ ð Þ
PredictedFEV1 ¼ 3:4132 – 0:0002484 x age2 years½ ð Þ
þ 0:04578 x height cm½ ð Þ
The highest FEV1 and FVC values from three or more
tests with acceptable curves were used for further ana-
lyses. The FVC (% predicted) and FEV1 (% predicted)
were calculated by dividing the FVC (L) and FEV1 (L) by
the predicted FVC and FEV1, respectively.
The reliability of the spirometry is proved in the previ-
ously published report [15].
Statistical analysis
Data are expressed as the mean ± standard deviation
(SD) for continuous variables and as percentages for
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transformed for analysis to correct skewed distributions,
but the values in the tables are expressed as untrans-
formed data for easy interpretation. Comparisons of base-
line cardiovascular risk factors according to the presence/
absence of incident type 2 diabetes were made using Stu-
dent’s t-test for continuous variables or the chi-square test
for categorical variables. Comparisons of baseline variables
between the lowest and highest quartiles of FEV1 (% pre-
dicted) or FVC (% predicted) were made by Student’s t-
test or the chi-square test. Comparisons of type 2 diabetes
development according to FEV1 (% predicted) or FVC
(% predicted) quartiles were obtained from chi-square
tests. Multivariable logistic regression analyses were con-
ducted to assess the relationship between FEV1 (% pre-
dicted) or FVC (predicted) quartiles and the risk of
incident type 2 diabetes: model 1 was adjusted for age and
BMI; model 2 was adjusted as in model 1 plus education,
smoking, exercise, alcohol, and insulin; model 3 was
adjusted as in model 1 plus education, smoking, exercise,
alcohol, and HOMA-IR. The outcome in this study was
type 2 diabetes at five years and all subjects had been fol-
lowed for approximately five years. Therefore, our data for
the analysis was complete (not censored) in terms of out-
come. For this reason, data was analyzed by logistic re-
gression instead of using a Cox regression model. All
statistical analyses were performed using PASW for Win-
dows, version 18.0 (SPSS Inc., Chicago, IL, USA). All statis-
tical tests were two-tailed, and P-values< 0.05 were
considered statistically significant.
Results
The overall incidence of type 2 diabetes in the study
population was 2.2% (207 of 9,220 men). According to
the quartiles of FVC (% predicted), the incidence of type 2
diabetes was 3.6% in the lowest quartile (quartile 1), 1.7%
in the second (quartile 2), 2.3% in the third (quartile 3),
and 1.3% in the highest quartile (quartile 4) (P< 0.0001).
Moreover, the difference in incidence of type 2 diabetes
according to the quartile of FEV1 (% predicted) was also
significant [3.1% in quartile 1, 2.3% in quartile 2, 1.9% in
quartile 3, and 1.7% in quartile 4 (P= 0.005)]. The overall
incidence of type 2 diabetes in the study group was similar
to that of the excluded subjects [2.2% (207/9,220) vs. 2.0%
(35/1,745), respectively, P = 0.438].
Clinical characteristics of the subjects according to
diabetes development at follow-up
Baseline characteristics of the non-diabetes group and
the diabetes group at follow-up are presented in Table 1.
Individuals in the diabetes group were older and more
likely to have higher mean BP, heart rate (HR), BMI, TC,
TG, glucose, insulin, and HOMA-IR, and lower HDL-C,
FEV1 (L), and FVC (L) values compared with those inthe non-diabetes group. In addition, there were more
subjects in the diabetes group who were obese, currently
smoking, and who had a low-level of education
(Table 1).
Baseline characteristics according to quartiles of FEV1
(% predicted) and FVC (% predicted)
The baseline characteristics of the lowest and highest
quartiles of FEV1 (% predicted) and FVC (% predicted)
were compared (Table 2). In the lowest quartile (quartile
1) of FEV1 (% predicted), TG, glucose and the percent-
age of current smokers were significantly higher com-
pared to the highest quartile (quartile 4). However, age,
HR, BMI, HDL-C, insulin and alcohol consumption
were significantly lower in the lowest quartile compared
to the highest quartile. On the other hand, subjects in
quartile 1 of FVC (% predicted) were older, more likely
to have higher BP, BMI, TG, glucose, insulin and
HOMA-IR, and had lower HR and HDL-C compared to
quartile 4.
Analysis of future risk for incidence of type 2 diabetes
after a five-year follow-up according to baseline lung
function and obesity
In age- and BMI-adjusted logistic regression analysis
(model 1), the lowest quartiles of FVC (% predicted) and
FEV1 (% predicted) had a higher odds ratio (OR) for the
incidence of type 2 diabetes compared to the highest
quartile reference category (OR [95% confidence interval
(CI)], 2.18[1.42-3.32] and 1.95[1.31-2.92], P< 0.0001 and
P= 0.001, respectively) (Table 3, Figure 1). The OR
results from models 2 and 3 were attenuated, but were
still significant in FVC (% predicted) and FEV1 (% pre-
dicted). Moreover, analysis with model 3 including age,
BMI, education, smoking, exercise, alcohol, and HOMA-
IR revealed that the ORs in FVC (% predicted) and FEV1
(% predicted) quartile 1 were significantly higher com-
pared with those in quartile 4 (OR [95% CI], 1.90[1.23-
2.93] and 1.66[1.10-2.50], P = 0.004 and P=0.019,
respectively).
We also conducted a sub-analysis of 5,417 non-obese
subjects with BMI <25 (mean BMI: 22.7 ± 1.6, range:
16.1 to 24.9) to evaluate the association between lung
function and type 2 diabetes in the non-obese popula-
tion. In the non-obese subjects with BMI <25, quartile 1
of FVC (% predicted) and FEV1 (% predicted) had a sig-
nificantly increased OR for type 2 diabetes compared to
quartile 4 after adjusting for age and BMI (OR[95% CI],
2.15[1.02-4.57] and 2.19[1.09-4.42], P = 0.045 and
P= 0.028, respectively) (Table 4).
Discussion
The major findings of this study are 1) the subjects with
reduced lung function as measured with FVC (%
Table 1 Baseline characteristics of the non-diabetic and




group (n = 207)
P value
Age (years) 41.3 ± 5.8 42.6 ± 5.6 0.002
Systolic BP (mmHg) 117.0 ± 12.4 122.6 ± 14.7 <0.0001
Diastolic BP (mmHg) 76.6 ± 9.3 80.3 ± 10.6 <0.0001
HR (n/min) 65.6 ± 8.8 68.5 ± 10.2 <0.0001
BMI (kg/m2) 24.4 ± 2.6 26.7 ± 3.3 <0.0001
TC (mmol/L) 5.42 ± 0.90 5.59 ± 0.94 0.007
TG (mmol/L) 1.73 ± 0.98 2.36 ± 1.64 <0.0001
HDL-C (mmol/L) 1.35 ± 0.26 1.28 ± 0.23 <0.0001
LDL-C (mmol/L) 3.16 ± 0.75 3.25 ± 0.73 0.072
Glucose (mmol/L) 5.20 ± 0.45 6.00 ± 0.50 <0.0001
Insulin (pmol/L) 50.58 ± 19.36 67.86 ± 31.88 <0.0001
HOMA-IR 1.69 ± 0.69 2.61 ± 1.24 <0.0001
FEV1 (L) 4.32 ± 0.81 4.13 ± 0.84 0.001
FVC (L) 4.88 ± 0.90 4.71 ± 0.86 0.010
FEV1 (%) 108.0 ± 18.7 103.5 ± 19.1 0.001
FVC (%) 100.2 ± 17.1 95.2 ± 15.3 <0.0001
Alcohol (g/day) 14.3 ± 16.1 16.6 ± 19.6 0.097
Weight class, n (%)
BMI <25 5,353 (59.4) 64 (30.9) <0.0001
BMI ≥25 3,659 (40.6) 143 (69.1)
Smoking status,
n (%)
Non-smoker 2,858 (31.7) 50 (24.2) 0.029
Ex-smoker 2,418 (26.8) 54 (26.1)
Current-smoker 3,736 (41.5) 103 (49.8)
Education status, n (%)
≤12 years 1,689 (18.7) 49 (23.7) 0.004
≤14 years 706 (7.8) 26 (12.6)
≥16 years 6,618 (73.4) 132 (63.8)
Regular exercise,
n (%)
None 2,221 (24.6) 47 (22.7) 0.44
<1 time/week 3,523 (39.1) 90 (43.5)
≥1 time/week 3,269 (36.2) 70 (33.8)
FVC (%) quartiles, n (%)
Q 1 (≤89.4) 2,221 (24.6) 84 (40.6) <0.0001
Q 2 (89.4-98.6) 2,265 (25.1) 40 (19.3)
Q 3 (98.6-109.1) 2,253 (25.0) 52 (25.1)
Q 4 (>109.1) 2,274 (25.2) 31 (15.0)
FEV1 (%) quartiles,
n (%)
Q 1 (≤94.6) 2,233 (24.8) 72 (34.8) 0.005
Q 2 (94.6-105.5) 2,252 (25.0) 53 (25.6)
Table 1 Baseline characteristics of the non-diabetic and
diabetic groups at follow-up (Continued)
Q 3 (105.5-119.9) 2,262 (25.1) 43 (20.8)
Q 4 (>119.9) 2,266 (25.1) 39 (18.8)
Values are mean ± SD for continuous variables and number (percentages) for
categorical variables. P values for continuous variables were obtained from the
Student’s t test. P values for categorical variables were obtained from Chi-
square tests. TG was expressed as raw data but was applied for statistical
analysis after natural logarithmic transformation.
BP, blood pressure; HR, heart rate; BMI, body mass index; TC, total cholesterol; TG,
triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low density
lipoprotein cholesterol; HOMA-IR, homeostasis model assessment – insulin
resistance; FEV1, forced expiratory volume in one second; FVC, forced vital capacity;
Q, quartile.
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of type 2 diabetes, independent of other confounding
factors including age, BMI, education, smoking, exercise,
alcohol and HOMA-IR; and 2) in non-obese subjects
with BMI <25, decreased FVC (% predicted) and FEV1
(% predicted) were also inversely and significantly corre-
lated with the incidence of type 2 diabetes. Our findings
are generally consistent with previous studies that
reported a significant association between reduced lung
function and type 2 diabetes [8-10,20,21].
Previous studies have reported that the risk of being rela-
tively insulin resistant, as measured by HOMA-IR, signifi-
cantly increased as lung function decreased [7,9,21]. In
the Normative Aging Study, 1,050 non-diabetic male sub-
jects were followed over 20 years. Lower FVC, FEV1, and
maximal mid-expiratory flow rate at baseline were signifi-
cantly associated with risk of hyperinsulinemia and esti-
mated insulin resistance [7]. Some epidemiologic and
clinical studies have found that decreased lung function
is associated with type 2 diabetes, independent of obesity
[8-10,21-23]. In Asia, a number of studies have reported
relationships between lung function and type 2 diabetes,
insulin resistance and metabolic syndrome (MS) [12-
15,24,25]. Although studies were limited by their cross-
sectional design or small cohorts, they suggested that FVC
and FEV1 could be predictive markers of incident type 2
diabetes or MS in Asian populations. Recently, The Strong
Heart Study reported that reduced lung function is inde-
pendently associated with diabetes, and impaired lung
function presents before the development of diabetes in
American Indians [23].
Type 2 diabetes is associated with insulin resistance
and glucose tolerance, which could originate from vis-
ceral obesity [26]. Yeh et al. found that abdominal obes-
ity is a significant factor affecting type 2 diabetes, MS,
and pulmonary function test results [23]. Another study
by Jung et al. [27] reported that nonalcoholic fatty liver
disease, a well-known marker for insulin resistance and
MS, was associated with reduced pulmonary function. In
our study, subjects in the diabetes group had a signifi-
cantly higher BMI and lower FVC and FEV1 (L) at
Table 2 Baseline characteristics according to quartiles of FEV1 (% predicted) and FVC (% predicted)










n 2305 2305 2305 2305
Age (years) 40.8 ± 5.7 41.9 ± 6.1 <0.0001 42.2 ± 6.5 40.9 ± 5.4 <0.0001
Systolic BP (mmHg) 117.5 ± 12.8 117.5 ± 12.6 0.989 118.0 ± 13.1 117.0 ± 12.2 0.008
Diastolic BP (mmHg) 77.2 ± 9.7 76.6 ± 9.3 0.039 77.5 ± 9.7 76.4 ± 9.1 <0.0001
HR (n/min) 65.1 ± 8.8 66.7 ± 9.2 <0.0001 65.5 ± 8.8 66.3 ± 9.2 0.002
BMI (kg/m2) 24.5 ± 2.8 24.7 ± 2.5 0.011 24.8 ± 2.8 24.3 ± 2.4 <0.0001
TC (mmol/L) 5.43 ± 0.93 5.48 ± 0.91 0.073 5.46 ± 0.92 5.44 ± 0.92 0.415
TG (mmol/L) 1.84 ± 1.14 1.72 ± 0.95 <0.0001 1.84 ± 1.14 1.68 ± 0.97 <0.0001
HDL-C (mmol/L) 1.32 ± 0.25 1.38 ± 0.26 <0.0001 1.33 ± 0.25 1.38 ± 0.26 <0.0001
LDL-C (mmol/L) 3.17 ± 0.76 3.19 ± 0.76 0.356 3.18 ± 0.74 3.17 ± 0.76 0.613
Glucose (mmol/L) 5.30 ± 0.46 5.13 ± 0.47 <0.0001 5.30 ± 0.47 5.12 ± 0.47 <0.0001
Insulin (pmol/L) 51.08 ± 20.63 52.40 ± 19.61 0.026 52.65 ± 21.16 50.94 ± 19.43 0.004
HOMA-IR 1.74 ± 0.77 1.73 ± 0.70 0.437 1.80 ± 0.79 1.68 ± 0.69 <0.0001
FEV1 (L) 3.46 ± 0.39 5.33 ± 0.59 <0.0001 3.57 ± 0.46 5.25 ± 0.67 <0.0001
FVC (L) 4.20 ± 0.96 5.77 ± 0.68 <0.0001 4.02 ± 0.41 5.88 ± 0.97 <0.0001
Alcohol (g/day) 13.4 ± 16.0 15.5 ± 16.6 <0.0001 14.3 ± 16.4 15.0 ± 16.6 0.166
Current smoker, n (%) 1053 (45.7) 906 (39.3) <0.0001 972 (42.2) 935 (40.6) 0.393
Values are mean ± SD for continuous variables. P values for continuous variables were obtained from the Student’s t test. TG was expressed as raw data but was
applied for statistical analysis after natural logarithmic transformation.
FEV1, forced expiratory volume in one second; FVC, forced vital capacity; BP, blood pressure; HR, heart rate; BMI, body mass index; TC, total cholesterol; TG,
triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment – insulin resistance.
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In addition, ventilatory function is partially determined
by respiratory muscle strength, which may be compro-
mised in obese subjects [28].Table 3 Multivariable logistic regression analysis for the asso
diabetes during a five-year follow-up
Type 2 diabetes Model 1
n (%) OR[95% CI] P
FVC
Q 1 84 (3.6) 2.18[1.42-3.32] <0.0001
Q 2 40 (1.7) 1.18[0.73-1.91] 0.487
Q 3 52 (2.3) 1.67[1.06-2.62] 0.026
Q 4 31 (1.3) 1
P value <0.0001*
FEV1
Q 1 72 (3.1) 1.95[1.31-2.92] 0.001
Q 2 53 (2.3) 1.59[1.04-2.43] 0.032
Q 3 43 (1.9) 1.20[0.77-1.86] 0.428
Q 4 39 (1.7) 1
P value 0.005*
*P value was obtained from Chi-square tests for the comparisons of the incident dia
Model 1 was adjusted for age and BMI.
Model 2 was adjusted as in model 1 plus education, smoking, exercise, alcohol and
Model 3 was adjusted as in model 1 plus education, smoking, exercise, alcohol, HO
FEV1, forced expiratory volume in one second; FVC, forced vital capacity; OR, odds
model assessment – insulin resistance; TC, total cholesterol; TG, triglyceride; HDL-C,The association between diminished lung function and
type 2 diabetes may be explained according to a common
inflammatory process [29]. Obesity and metabolic syn-
drome are associated with elevated systemic inflammatoryciation between lung function and incident type 2
Model 2 Model 3
OR[95% CI] P OR[95% CI] P
2.00[1.30-3.07] 0.002 1.84[1.19-2.84] 0.006
1.16[0.72-1.87] 0.548 1.11[0.69-1.80] 0.665
1.64[1.04-2.59] 0.032 1.66[1.05-2.62] 0.030
1 1
1.78[1.18-2.67] 0.006 1.58[1.04-2.39] 0.030
1.54[1.01-2.36] 0.047 1.46[0.95-2.25] 0.082
1.14[0.73-1.79] 0.555 1.08[0.69-1.70] 0.734
1 1
betes among quartiles of FVC (% predicted) and FEV1 (% predicted).
insulin.
MA-IR, TC, TG, and HDL-C.








Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
VEFCVF 1
Figure 1 Odds ratio for the development of type 2 diabetes according to quartiles of baseline lung function during a five-year follow-
up. FVC, forced vital capacity (% predicted); FEV1, forced expiratory volume in one second (% predicted).
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tion of increased oxidative activity, intracellular NF-kB and
inflammatory mediators could also result in chronic hyper-
glycemia and an increase in collagen molecule synthesis
and cross-linking via the acceleration of advanced glycation
end-products, ultimately negatively influencing lungTable 4 Multivariable logistic regression analysis for the asso
diabetes in non-obese subjects (BMI< 25) during a five-year
Type 2 diabetes Model 1
n (%) OR[95% CI] P
FVC
Q 1 23 (1.7) 2.15[1.02-4.57] 0.045
Q 2 16 (1.2) 1.60[0.72-3.54] 0.247
Q 3 15 (1.1) 1.50[0.67-3.36] 0.322
Q 4 10 (0.7) 1
P value 0.142*
FEV1
Q 1 24 (1.8) 2.19[1.09-4.42] 0.028
Q 2 14 (1.0) 1.30[0.60-2.83] 0.508
Q 3 14 (1.0) 1.23[0.56-2.66] 0.608
Q 4 12 (0.9) 1
P value 0.135*
*P value was obtained from Chi-square tests for the comparison of incident diabete
Model 1 was adjusted for age and BMI.
Model 2 was adjusted as in model 1 plus education, smoking, exercise, alcohol and
Model 3 was adjusted as in model 1 plus education, smoking, exercise, alcohol, HO
FEV1, forced expiratory volume in one second; FVC, forced vital capacity; OR, odds
model assessment – insulin resistance; TC, total cholesterol; TG, triglyceride; HDL-C,function [31]. Moreover, previous studies have indicated
that proinflammatory cytokines such as C-reactive protein
(CRP), fibrinogen and IL-6 may play a role in the pathogen-
esis of type 2 diabetes [10,13,15,23], although a recent study
showed no association of glucose control with hs-CRP [32].
However, we could not address the association betweenciation between lung function and incident type 2
follow-up
Model 2 Model 3
OR[95% CI] P OR[95% CI] P
2.06[0.97-4.38] 0.061 1.93[0.90-4.12] 0.091
1.55[0.70-3.45] 0.279 1.47[0.66-3.28] 0.346
1.53[0.68-3.42] 0.305 1.51[0.67-3.41] 0.317
1 1
2.06[1.02-4.17] 0.044 1.87[0.92-3.80] 0.084
1.25[0.57-2.72] 0.581 1.17[0.53-2.57] 0.694
1.23[0.56-2.68] 0.602 1.19[0.54-2.60] 0.665
1 1
s among quartiles of FVC (% predicted) and FEV1 (% predicted).
insulin.
MA-IR, TC, TG, and HDL-C.
ratio; CI, confidence interval; BMI, body mass index; HOMA-IR, homeostasis
high-density lipoprotein cholesterol.
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jects did not have available measurements of inflammatory
markers such as CRP and IL-6.
Limitations
We note that our study had some limitations. First, there
is the possibility of selection bias because most partici-
pants were residents of an urban community, all subjects
were of Korean descent, from one university hospital, and
there were no women in this study. Therefore, the results
of this study cannot be generalized to the worldwide popu-
lation. Second, incident type 2 diabetes was defined based
only on fasting glucose level or a self-reported medical his-
tory of type 2 diabetes, and no oral glucose tolerance tests
were performed. Thus, the incidence of type 2 diabetes
may have been underestimated in this study. Third, risk of
diabetes may have been influenced by early life style fac-
tors which was not investigated in this study. Therefore,
future studies including birth cohort analysis are needed
to clarify the cause-effect link between reduced lung func-
tion and risk of developing diabetes. Finally, our data con-
sisted of only baseline and five-year follow-up time points.
The outcome was considered the presence of type 2 dia-
betes at five years. Thus, logistic regression was used for
analysis instead of a Cox regression model. However, our
study had the advantage of including a relatively large total
number of subjects over a relatively long follow-up period.
Conclusions
In conclusion, decreased FVC (% predicted) and FEV1 (%
predicted) were significantly associated with the incidence
of type 2 diabetes in Korean men. This result suggests that
reduced lung function as measured by FVC and FEV1
might precede the development of type 2 diabetes. Further
prospective studies will be required to confirm the associ-
ation between reduced lung function and diabetes in
Asian populations.
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